valery, good afternoon, good afternoon, pavel! so, valery, at what stage is the development of this miracle vaccine now, dare i say it? at this stage, we have completely completed preclinical studies, that is , animal studies that evaluate the effectiveness and safety of this vaccine, at the moment, together with our strategic industrial partner generium, we we are finishing production of a pilot one. against which it will be possible to make a similar vaccine, most likely it will also be a vaccine against pollen, but other plants, for example, if we take the southern regions, allergies to ragweed pollen are more typical there than to birch pollen, at least there are also birch pollen, therefore this can be called a whole platform for creating this kind of vaccine, the principle will be the same, the principle will be the same. the only negative, of course, for each vaccine of this kind, according to the current regulatory and legislative requirements requirements, separate preclinical clinical trials will be required, which will